TO THE EDITOR
We read with interest the recent paper by Primo et al 1 that describes atypical interphase fluorescence in situ hybridisation (FISH) patterns of BCR/ABL gene rearrangement in chronic myeloid leukaemia (CML) and Ph-positive acute leukaemia. In particular, the loss of one red signal in BCR/ABL dual colour extra signal (ES) probe system is found to be genetically heterogeneous, and may represent either derivative chromosome 9q deletions or cryptic insertion of BCR at 9q34. While the former aberration is well described, 2 the latter event is unusual 3 and has hitherto not been thoroughly evaluated using different readily available FISH probe systems. We present the atypical FISH patterns in a case of CML with BCR/ABL fusion on 9q as a result of cryptic insertion of BCR at 9q34, and discuss their interpretation.
A 9-year-old girl was admitted because of continuous oozing of blood from the hard palate after a minor abrasion. Physical examination showed crusted lesions on the left C8-T1 region compatible with herpes zoster. No petechiae or hepatosplenomegaly was detected. Complete blood counts revealed: haemoglobin 11.3 g/dl, white cell count 45 Â 10 9 /l and platelets 1917 Â 10 9 /l. Blood film showed circulating blasts (2%), immature granulocytes and basophilia. Bone marrow examination showed findings typical of chronic phase CML. Conventional cytogenetic analysis of bone marrow cells showed normal karyotype. Both chromosomes 9 and 22 were morphologically normal on G-banding (Figure 1a) , without Ph translocation. Interphase FISH using BCR/ABL dual colour dual fusion (D-FISH) probe system (Vysis Inc., Downer's Grove, IL, USA) showed an atypical one red, two green and one fusion (1R2G1F) pattern in 93% of cells among 300 cells analysed (Figure 1b) . A normal clone (7%) with 2R2G pattern was present. Although metaphase FISH on G-banded metaphases showed fusion signal on chromosome 9, red fluorescence signal (ie the 3 0 end of the ABL gene) was not detected on chromosome 22 (Figures 1c and  d) . The presence of the BCR-ABL gene fusion on chromosome 9 was subsequently confirmed by metaphase FISH on G-banded metaphases using both BCR/ABL dual colour signal fusion (S-FISH) and ES-FISH translocation probes (Vysis) (Figures 1e and  f) . Furthermore, the absence of residual green fluorescence signal on the der(22) chromosome was consistent with M-BCR breakpoint on chromosome 22 (Figure 1e ). Taken together, results indicated a cryptic insertion of BCR at 9q34 leading to BCR/ABL fusion on chromosome 9q. Our case did not show the typical 1R1G2F pattern on interphase D-FISH, suggesting that the cryptic insertion of BCR at 9q34 was the primary cytogenetic event.
Interphase FISH is increasingly used for the detection of BCR/ ABL rearrangements in CML patients, 4 both at diagnosis and for monitoring disease response to therapy. Using cryptic insertion of BCR at 9q34 as an example, we have illustrated that, in clinical practice, atypical interphase FISH results should not be interpreted in isolation, and should be integrated with information gathered through conventional cytogenetics, metaphase FISH, and if necessary molecular genetic studies. The location of BCR/ABL gene fusion on chromosomes other than 22q constitutes a rare form of variant Ph translocation. 5 Mechanistically, the chromosomal rearrangements underlying aberrant localisation of BCR/ABL fusion can only be delineated by FISH techniques. There are two points of note in the present case. First, for cryptic insertion of BCR at 9q34, both ours and several previously reported cases 3, 6, 7 showed normal chromosomes 9 and 22 (ie Ph chromosome negative). Therefore, in Ph-negative BCR/ ABL-positive CML, the absence of extra red signal on interphase ES-FISH and 1R2G1F pattern on interphase D-FISH should raise the possibility of cryptic insertion of BCR at 9q34. Second, even despite G-banded metaphase D-FISH, the presence of BCR/ABL fusion could not be definitely ascertained in the present case, as the fusion signal on 9q may be interpreted as reciprocal ABL/ BCR fusion. We propose that, besides molecular detection of BCR/ABL fusion, the simplest way would be to perform ES-FISH or S-FISH to confirm the presence of BCR/ABL gene fusion. We read with interest the letter to the editor by Wan et al 1 in which the interphase FISH (iFISH) patterns of a CML child showing an infrequent BCR/ABL translocation involving both chromosomes 9 and 22 is reported. The iFISH pattern observed consisted of one red, two green and one fusion (1R2G1F) signals once the BCR/ABL dual-color dual fusion (D-FISH) (Vysis Inc., Downer's Grove, IL, USA) probe was applied, and one red, one green and one fusion (1R1G1F) fluorescence dots with the BCR/ ABL ES (Vysis) probe coincident with what we recently described for CML patients with cryptic insertion of BCR in 9q34. 2 Despite the observation of a normal karyotype, the presence of the BCR/ABL gene fusion on chromosome 9 was confirmed by FISH on metaphase chromosomes, using the two mentioned probes plus a third BCR/ABL dual-color signal fusion (S-FISH) probe (Vysis). 1 In an updated series of 182 CML patients, we have found 15 cases (8%) showing similar patterns with the ES probe: one red, one green and one fused red/green signal (1R1G1F). This is in line with the previously published incidence of this pattern. 2, 3 In most of these 15 cases (n ¼ 13; 7%), the presence of an extensive del(9q) was confirmed by metaphase analyses with both the ES and the D-FISH probes; all of them showed a typical Ph chromosome on conventional cytogenetics. In contrast, two patients (1%) had a normal karyotype with no Ph chromosome being detected; the BCR/ABL gene rearrangements observed in both cases were due to a cryptic insertion of BCR in 9q34, as confirmed by metaphase FISH. These findings, together with those of Wan et al, 1 would support the notion that, in patients in whom a CML is suspected to show an iFISH pattern consistent with an apparent 9q
À and a Ph-negative karyotype, interphase and metaphase FISH investigation of atypical BCR/ABL gene rearrangements should be searched to confirm the presence of cryptic BCR insertion in 9q34. As already mentioned in our previous work, 2 in none of our two cases, neither in the one reported by Wan et al, 1 nuclei carrying a typical MBCR/ABL gene translocation were simultaneously found. These results would further support that this aberrant localization of the BCR/ ABL fused gene may result from an insertion of a chromosome 22 segment comprising the 5 0 side of the BCR 4,5 gene rather than from two sequential translocations, the classical t(9;22) followed by a reverse translocation between the two derivative chromosomes 9 and 22. [6] [7] [8] Previous reports have extensively described the genetic abnormalities occurring in CML patients with cryptic insertion of the BCR gene in 9q34. To the best of our knowledge, 25 CML cases carrying this infrequent BCR/ABL gene rearrangement have been reported so far, 4-24 all of them corresponding to Ph-negative CML patients. We would like to take this opportunity to expand on the clinical characteristics of these infrequent CML patients.
In contrast to the case reported by Wan et al, 1 our two cases as well as most of those reported in the literature 4-24 were adults; both showed splenomegaly and moderate leukocytosis and thrombocytosis (Table 1) . Treatment was carried out with hydroxyurea plus IFN-a in one case and with only hydroxyurea in the other patient, both achieving hematological remission in the absence of a complete cytogenetic response in molecular
